For years, Alzheimer’s disease (AD) has remained a formidable challenge for patients, families, and researchers. One of the most heartbreaking realities for many is the phrase: “There is no cure.” Although several new treatments have emerged over the past few decades, options that tangibly improve memory and cognitive function in daily life remain limited.

Discover how GLP-1 receptor agonists like semaglutide spotlight energy metabolism as the nexus of obesity and aging—and explore actionable insights and research tools to balance metabolic health.